International Aids Vaccine Initiative Inc

Organization Overview

International Aids Vaccine Initiative Inc, operating under the name Iavi, is located in New York, NY. The organization was established in 1996. According to its NTEE Classification (Q30) the organization is classified as: International Development, under the broad grouping of International, Foreign Affairs & National Security and related organizations. As of 12/2023, Iavi employed 268 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Iavi is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2023, Iavi generated $129.7m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 6.7% each year. All expenses for the organization totaled $132.9m during the year ending 12/2023. While expenses have increased by 7.8% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Since 2015, Iavi has awarded 141 individual grants totaling $60,363,299. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2023

Describe the Organization's Mission:

Part 3 - Line 1

TRANSLATE SCIENTIFIC DISCOVERIES INTO AFFORDABLE, GLOBALLY ACCESSIBLE PUBLIC HEALTH SOLUTIONS

Describe the Organization's Program Activity:

Part 3 - Line 4a

RESEARCH AND DEVELOPMENT: THROUGH SCIENTIFIC AND CLINICAL RESEARCH IN AFRICA, INDIA, EUROPE, AND THE U.S., IAVI DEVELOPS VACCINES AND ANTIBODIES IN AND FOR THE DEVELOPING WORLD AND SEEKS TO ACCELERATE THEIR INTRODUCTION IN LOW-INCOME COUNTRIES. IAVI ADVANCES SCIENTIFIC DISCOVERY AND DEVELOPMENT BY FOSTERING UNIQUE COLLABORATIONS AMONG ACADEMIA, INDUSTRY, LOCAL COMMUNITIES, GOVERNMENTS, AND FUNDERS TO EXPLORE NEW AND BETTER WAYS TO ADDRESS PUBLIC HEALTH THREATS THAT DISPROPORTIONATELY AFFECT PEOPLE LIVING IN POVERTY. VACCINE AND ANTIBODY CANDIDATES ARE PUT THROUGH A RIGOROUS PROCESS OF CLINICAL EVALUATION AMONG KEY POPULATIONS TO ESTABLISH THEIR SAFETY AND EFFICACY, AN EFFORT THAT ENABLES IAVI TO STRENGTHEN THE HEALTHCARE INFRASTRUCTURE AND SCIENTIFIC CAPACITY OF COUNTRIES WHERE OUR CLINICAL PARTNERS OPERATE. TO DATE, IAVI AND ITS PARTNERS HAVE ADVANCED DOZENS OF HIV VACCINE CANDIDATES INTO EARLY STAGE CLINICAL TRIALS, INCLUDING A VACCINE THAT RECENTLY YIELDED PROMISING RESULTS AND IS PART OF AN EXCITING NEW APPROACH TO HIV VACCINE DESIGN. OTHER NOTABLE ACHIEVEMENTS INCLUDE THE FIRST HIV VACCINE TRIALS IN SUB-SAHARAN COUNTRIES, WHERE HIV BURDEN IS GREATEST, AND THE FIRST TRIAL OF AN MRNA HIV VACCINE CANDIDATE IN AFRICA. IAVI HAS CONDUCTED MORE THAN 50 EPIDEMIOLOGICAL STUDIES AND PROVIDED VOLUNTARY HIV TESTING, COUNSELING SERVICES, AND HEALTH CARE REFERRALS TO MORE THAN 870,000 INDIVIDUALS IN AFRICA. IAVI ALSO SUPPORTS PRECLINICAL DEVELOPMENT AND CLINICAL TESTING OF VACCINE CANDIDATES FOR OTHER DISEASES, INCLUDING TUBERCULOSIS, LASSA FEVER, MARBURG, EBOLA SUDEN, AND COVID-19, AS WELL AS ANTIBODY CANDIDATES FOR DISEASE PREVENTION AND TREATMENT. IAVI CONDUCTS TRIALS WITH THE HIGHEST SCIENTIFIC AND ETHICAL STANDARDS TO PROTECT THE RIGHTS, WELL-BEING, AND DIGNITY OF TRIAL VOLUNTEERS. IAVI HAS ALSO LAUNCHED RESEARCH CONSORTIA TO ADDRESS MAJOR SCIENTIFIC PROBLEMS OF BIOMEDICAL PRODUCT DEVELOPMENT. A SIGNIFICANT PORTION OF THE RESEARCH IAVI SUPPORTS IS CONDUCTED IN DEVELOPING COUNTRIES WHERE THE NEED FOR INFECTIOUS DISEASE PREVENTION IS GREATEST. IAVI ALSO SUPPORTS EXTERNAL RESEARCHERS BY PROVIDING TECHNICAL AND SCIENTIFIC EXPERTISE TO ACCELERATE THE DEVELOPMENT OF THEIR OWN PRODUCTS.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Mark B Feinberg
President/ceo
$719,151
Eric Paul Goosby
Board Chair
$0
Robert Goldberg
Board Treasurer
$0
Linda-Gail Becker
Board Member
$0
David Blumberg
Board Member
$0
Jim Connolly
Board Member
$0

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Emmes Corporation
Clinical Research Studies
$1,245,043
Australian Biologics Pty Ltd
Regulatory Consultant
$401,508
Wits Health Consort
Program Consultant
$267,425
Armstrong Teasdale
Legal Services
$241,508
Us Medical Equip Cons Inc
Equipment Maintenance
$219,338
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $70,009,700
All other contributions, gifts, grants, and similar amounts not included above$54,577,973
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$124,587,673
Total Program Service Revenue$2,297,276
Investment income $3,256,766
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales -$494,343
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $129,678,400

Grants Awarded

Over the last fiscal year, International Aids Vaccine Initiative Inc has awarded $9,190,196 in support to 23 organizations.

Grant RecipientAmount

THE SCRIPPS RESEARCH INSTITUTE - OSP

PURPOSE: RESEARCH & DEVELOPMENT

$3,088,050

TEXAS BIOMEDICAL RESEARCH INSTITUTE

PURPOSE: RESEARCH & DEVELOPMENT

$1,667,115

LA JOLLA INSTITUTE FOR ALLERGY & IMMUNOLOGY

PURPOSE: RESEARCH & DEVELOPMENT

$592,672

EMORY UNIVERSITY

PURPOSE: RESEARCH & DEVELOPMENT

$462,130

THE UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON

PURPOSE: RESEARCH & DEVELOPMENT

$453,031

BOSTON UNIVERSITY

PURPOSE: RESEARCH & DEVELOPMENT

$432,798
View Grant Profile

Peer Organizations

Organization NameAssets
Medecins Sans Frontieres Usa Inc
New York, NY
$688,743,776
Catholic Medical Mission Board Inc
Long Island City, NY
$364,098,469
Hadassah Medical Relief Association Inc
New York, NY
$50,906,481
Project Orbis International Inc
New York, NY
$362,900,663
Vital Strategies Inc
New York, NY
$104,242,576
Management Sciences For Health Inc
Medford, MA
$145,424,118
International Aids Vaccine Initiative Inc
New York, NY
$129,678,400
Action Against Hunger Usa
New York, NY
$130,585,672
Myriad Usa Inc
New York, NY
$121,394,713
Helen Keller International
New York, NY
$145,494,796
American Society For Technion- Israel Institute Of Technology Inc
New York, NY
$86,399,228
Brothers Brother Foundation
Pittsburgh, PA
$99,353,737
Concern Worldwide U S Inc
New York, NY
$83,957,773
Central European University
New York, NY
$20,041,991
Jewish National Fund -Keren Kayemeth Leisrael- Inc
New York, NY
$140,855,420
Oxfam-America Inc
Boston, MA
$83,115,051
Pro Mujer Inc
New York, NY
$75,116,159
The American College Of Greece
Boston, MA
$59,872,948
End Fund Inc
New York, NY
$56,392,358
World Education Inc
Boston, MA
$48,101,068
American Jewish World Service Inc
New York, NY
$42,598,085
Mass Design Group
Boston, MA
$45,865,852
Hope International
Lancaster, PA
$37,095,644
Citihope International Inc
Margaretsville, NY
$19,381,397
International Planned Parenthood Federation
New York, NY
$24,831,284

Create an account to unlock the data you need.

or